Get the Stockscreener App
423.99
1.25%
5.24
After Hours:
423.99
Idexx Laboratories Inc stock is traded at $423.99, with a volume of 498.64K.
It is up +1.25% in the last 24 hours and up +2.72% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$418.75
Open:
$424.29
24h Volume:
498.64K
Relative Volume:
0.78
Market Cap:
$34.72B
Revenue:
$3.84B
Net Income/Loss:
$866.24M
P/E Ratio:
40.89
EPS:
10.37
Net Cash Flow:
$792.60M
1W Performance:
-1.93%
1M Performance:
+2.72%
6M Performance:
-10.68%
1Y Performance:
-18.62%
1-Day Range:
$420.86
$431.38
1-Week Range:
$405.84
$437.62
52-Week Range:
$398.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
423.99 | 34.72B | 3.84B | 866.24M | 792.60M | 10.37 |
|
TMO
Thermo Fisher Scientific Inc
|
606.74 | 232.08B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
223.08 | 160.42B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
151.38 | 42.01B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.78 | 36.62B | 15.32B | 1.41B | 1.96B | 7.62 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $550.00 at Morgan Stanley - MarketBeat
New England Research & Management Inc. Has $866,000 Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Sumitomo Life Insurance Co. Sells 1,370 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Assessing IDEXX Laboratories: Insights From 4 Financial Analysts - Benzinga
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Insider Monkey
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $550 From $559, Maintains Overweight Rating - Marketscreener.com
IDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 8.4% CAGR over the last five years - Yahoo Finance
Maine’s 10 Highest Paid Executives - 94.9 WHOM
Fifth Third Bancorp Sells 3,708 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Union Bancaire Privee UBP SA Buys New Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by KBC Group NV - MarketBeat
IDXX Gears Up for Q4 Earnings: What to Expect From the Stock? - MSN
IDEXX Laboratories (IDXX) Projected to Post Quarterly Earnings on Monday - MarketBeat
Flagship Harbor Advisors LLC Sells 2,073 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
First Citizens Bank & Trust Co. Sells 595 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Janney Montgomery Scott LLC Makes New Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
B.O.S.S. Retirement Advisors LLC Invests $1.69 Million in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know - MSN
IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch - MSN
IDEXX Laboratories (IDXX) Stock Price, News & Analysis - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stake Raised by Manitou Investment Management Ltd. - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by SG Americas Securities LLC - MarketBeat
Crossmark Global Holdings Inc. Sells 865 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Starting Soon It'll Cost You More to Mail Something in Maine - b985.fm
Beacon Investment Advisory Services Inc. Sells 7,079 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Riverbridge Partners LLC Reduces Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Wendell David Associates Inc. - MarketBeat
IDEXX Launches Breakthrough $15 Blood Test for Early Dog Cancer Detection: Cancer Dx Coming 2025 - StockTitan
Nisa Investment Advisors LLC Sells 2,845 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Bourne Lent Asset Management Inc. - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Park Avenue Securities LLC - Defense World
Mogy Joel R Investment Counsel Inc. Increases Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Legal Advantage Investments Inc. Buys 1,440 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Holdings Lowered by UMB Bank n.a. - MarketBeat
Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX) Target Price at $523.86 - Defense World
Short Interest in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Rises By 7.1% - MarketBeat
273,567 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Acquired by Seilern Investment Management Ltd - MarketBeat
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing? - Yahoo Finance
Sax Wealth Advisors LLC Increases Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
RDA Financial Network Purchases 834 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Carderock Capital Management Inc. Reduces Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Avanza Fonder AB Purchases New Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Gateway Investment Advisers LLC Purchases 1,274 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Oak Thistle LLC Makes New $426,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results - Business Wire
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Position Reduced by Claro Advisors LLC - MarketBeat
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):